Trump Orders Study on Transition Regret at NIH

The Trump administration has directed the National Institutes of Health to research regret and detransition among individuals who have undergone gender transition, raising questions about federal health priorities. The order targets both children and adults, fueling debate over its intent and potential impact.

The directive reportedly seeks data on outcomes. It focuses on psychological and social effects.

Critics claim it targets transgender healthcare. They fear it could restrict access to treatments.

Supporters argue it addresses valid medical questions. They say regret is understudied in transitions.

NIH scientists are tasked with the study. No timeline for results has been announced.

Transgender care is a polarizing national issue. States have passed conflicting laws on access.

The order aligns with Trump’s policy shifts. He’s emphasized traditional views on gender issues.

Advocacy groups are preparing to respond. Some plan to challenge the study’s framing.

Detransition rates are debated among experts. Reliable data remains limited and contested.

The study could influence future regulations. Its findings may shape insurance and care policies.

Public reaction has been sharply divided. Social media reflects deep cultural divides.

NIH’s independence is under scrutiny now. Critics worry about political influence on science.